{"id":"liv-gamma-sn-inj-10","safety":{"commonSideEffects":[{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Fever"},{"rate":null,"effect":"Chills"},{"rate":null,"effect":"Myalgia"},{"rate":null,"effect":"Infusion site reactions"},{"rate":null,"effect":"Thrombosis"},{"rate":null,"effect":"Aseptic meningitis"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"This is a 10% intravenous immunoglobulin derived from human plasma that contains a broad spectrum of antibodies against various pathogens and antigens. It functions by providing immediate passive immunization, neutralizing pathogens, enhancing opsonization and complement activation, and modulating inflammatory immune responses through Fc receptor engagement and idiotypic interactions.","oneSentence":"LIV-GAMMA SN is an intravenous immunoglobulin (IVIG) preparation that provides passive immunity by delivering pooled human antibodies to modulate immune responses.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:17:50.461Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Primary immunodeficiency disorders"},{"name":"Immune thrombocytopenia (ITP)"},{"name":"Chronic inflammatory demyelinating polyneuropathy (CIDP)"},{"name":"Kawasaki disease"}]},"trialDetails":[{"nctId":"NCT05566990","phase":"PHASE3","title":"A Clinical Study to Evaluate the Efficacy and Safety of LIV-GAMMA SN Inj.10% in Primary Immune Thrombocytopenia (ITP)","status":"COMPLETED","sponsor":"SK Plasma Co., Ltd.","startDate":"2019-07-19","conditions":"Immune Thrombocytopenia","enrollment":34}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"LIV-GAMMA SN Inj.10%","genericName":"LIV-GAMMA SN Inj.10%","companyName":"SK Plasma Co., Ltd.","companyId":"sk-plasma-co-ltd","modality":"Biologic","firstApprovalDate":"","aiSummary":"LIV-GAMMA SN is an intravenous immunoglobulin (IVIG) preparation that provides passive immunity by delivering pooled human antibodies to modulate immune responses. Used for Primary immunodeficiency disorders, Immune thrombocytopenia (ITP), Chronic inflammatory demyelinating polyneuropathy (CIDP).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}